Colgate-Palmolive (NYSE:CL) Shares Sold by OVERSEA CHINESE BANKING Corp Ltd

OVERSEA CHINESE BANKING Corp Ltd trimmed its position in Colgate-Palmolive (NYSE:CL) by 62.0% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 49,478 shares of the company’s stock after selling 80,762 shares during the quarter. OVERSEA CHINESE BANKING Corp Ltd’s holdings in Colgate-Palmolive were worth $4,499,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Kohmann Bosshard Financial Services LLC acquired a new stake in Colgate-Palmolive in the 4th quarter worth about $26,000. Centricity Wealth Management LLC purchased a new position in Colgate-Palmolive in the 4th quarter worth approximately $27,000. Union Bancaire Privee UBP SA purchased a new position in Colgate-Palmolive in the 4th quarter worth approximately $32,000. Briaud Financial Planning Inc purchased a new position in Colgate-Palmolive in the 4th quarter worth approximately $32,000. Finally, Wintrust Investments LLC purchased a new position in Colgate-Palmolive in the 4th quarter worth approximately $33,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $89.45 on Wednesday. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The company has a fifty day simple moving average of $89.13 and a two-hundred day simple moving average of $94.44. The company has a market cap of $72.59 billion, a price-to-earnings ratio of 25.41, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a 52 week low of $85.32 and a 52 week high of $109.30.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the prior year, the company earned $0.87 earnings per share. As a group, equities analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

CL has been the topic of a number of research reports. UBS Group decreased their target price on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research note on Monday, February 3rd. Piper Sandler decreased their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research note on Monday, January 6th. Wells Fargo & Company reduced their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. Stifel Nicolaus reduced their price target on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research report on Monday, February 3rd. Finally, Raymond James reaffirmed an “outperform” rating and set a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $101.72.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.